Breathe Well Live Well
|
KaloBios Pharma pulls plug on asthma drug, shares plunge
Reuters (Reuters) – Shares of KaloBios Pharmaceuticals Inc fell nearly 50 percent in extended trade after the company said it would stop developing an asthma drug that failed in a mid-stage study. The drug, KB003, failed to bring about a clinically meaningful … KaloBios stock slides; to stop asthma study KaloBios: KB003 Fails To Meet Primary Goal In Phase 2 Asthma Study |
View full post on asthma – Google News
Drug Discovery & Development |
GSK, Theravance asthma drug shows improved lung function in study
Reuters The drug, already approved in the U.S. to treat chronic obstructive pulmonary disease (COPD) under the brand name Breo, proved more effective than fluticasone furoate alone for patients with moderate to severe asthma at the end of a 12-week treatment … GSK, Theravance Report Positive Results For FF/VI In Late Stage Asthma Study Theravance and Glaxo say asthma study succeeded |
View full post on asthma – Google News
|
Kids with asthma still exposed to secondhand smoke
Reuters The fact that kids with asthma are still inhaling others' smoke is a real problem, said Dr. Karen M. Wilson, who studies children's' exposure to secondhand smoke at Children's Hospital Colorado in Aurora. "Secondhand smoke consists of particulate … |
View full post on asthma – Google News
The Denver Channel |
Rigel drops asthma drug after trial fails, stock hits life-low
Reuters (Reuters) – Rigel Pharmaceuticals Inc said it will stop developing its experimental asthma drug after the therapy failed in a mid-stage trial, sending its shares down as much as 17 percent to a life-low. The failure of the inhaled drug is the latest … Rigel Shares Plunge After Asthma Drug Fails to Meet Goals Rigel shares slide after another drug flops in PhII asthma study Rigel Pharmaceuticals skids after asthma drug fails in study |
View full post on asthma – Google News
|
Asthma more common, severe among obese kids: study
Reuters NEW YORK (Reuters Health) – Overweight and obese children are more likely to be diagnosed with asthma, according to a new study – and when they do have the condition, it tends to be more severe than in normal weight youth. Researchers found that … Obese youth more likely to develop asthma Overweight kids at higher risk of asthma Higher asthma risk for overweight kids |
View full post on asthma – Google News
|
Kids' asthma more likely to linger with pet allergies
Reuters Risk factors for asthma are complex and make it hard to predict which kids with wheezing or shortness of breath will still have those problems years later, Andersson told Reuters Health. As with previous research, the new study found that girls were … |
View full post on asthma – Google News
|
Array asthma drug meets main goal in mid-stage study
Reuters (Reuters) – Array Biopharma Inc said one of its drugs met the main goal of improving lung function in a mid-stage study among patients with mild to moderate persistent allergic asthma. Array shares rose as much as 19 percent to $6.64 — their highest … |
View full post on asthma – Google News
 Investorplace.com |
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
Reuters May 21 (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease … New Asthma Drug Generates Excitement For Patients — And Its Maker Antibody Gets High Marks for Asthma Control – MedPage Today Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial |
View full post on asthma – Google News
|
Regeneron, Sanofi asthma drug seen as potential game changer
Reuters (Reuters) – A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers … Monoclonal antibody appears effective and safe in asthma Phase IIa trial Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of … |
View full post on asthma – Google News
 U.S. News & World Report |
US-born kids have more allergies, asthma
Reuters NEW YORK (Reuters Health) – Kids and teens who are born abroad and immigrate to the United States are about half as likely to have asthma and allergies as those who are born in the U.S., according to a new study. Researchers surveyed the parents of … Are You Allergic to the United States? Being Born in the U.S. Increases Children's Risk of Allergic Diseases Kids born outside the US have lower allergy risk |
View full post on asthma – Google News